INM vs TSM
InMed Pharmaceuticals Inc (INM) versus TSM (TSM) — a side-by-side from cached financials, not a winner call.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
TSM (TSM) common stock.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
TSM does not have a complete income-statement cache yet.
INM currently screens at market cap $5.2M. TSM currently screens at market cap $0.
Not investment advice. Open the INM and TSM stock pages for the full models.
Not investment advice.